{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:10:14Z","timestamp":1788480614663,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:00:00Z","timestamp":1520899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:00:00Z","timestamp":1520899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The oligomerization and fibrillation of human islet amyloid polypeptide (hIAPP) play a central role in the pathogenesis of type 2 diabetes. Strategies for remodelling the formation of hIAPP oligomers and fibrils have promising application potential in type 2 diabetes therapy. Herein, we demonstrated that PEG-PE micelle could inhibit hIAPP oligomerization and fibrillation through blocking the hydrophobic interaction and the conformational change from random coil to \u03b2-sheet structures of hIAPP. In addition, we also found that PEG-PE micelle could remodel the preformed hIAPP fibrils allowing the formation of short fibrils and co-aggregates. Taken together, PEG-PE micelle could rescue hIAPP-induced cytotoxicity by decreasing the content of hIAPP oligomers and fibrils that are related to the oxidative stress and cell membrane permeability. This study could be beneficial for the design and development of antiamyloidogenic agents.<\/jats:p>","DOI":"10.1038\/s41598-018-22820-w","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T16:00:27Z","timestamp":1520438427000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Dual effect of PEG-PE micelle over the oligomerization and fibrillation of human islet amyloid polypeptide"],"prefix":"10.1038","volume":"8","author":[{"given":"Xiaocui","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Yousaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunxing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4318-7672","authenticated-orcid":false,"given":"Yanlian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,13]]},"reference":[{"key":"22820_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nature02621","volume":"430","author":"MP Mattson","year":"2004","unstructured":"Mattson, M. P. Pathways towards and away from Alzheimer\u2019s disease. Nature 430, 631\u2013639 (2004).","journal-title":"Nature"},{"key":"22820_CR2","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/nature02264","volume":"426","author":"DJ Selkoe","year":"2003","unstructured":"Selkoe, D. J. Folding proteins in fatal ways. Nature 426, 900\u2013904 (2003).","journal-title":"Nature"},{"key":"22820_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3109\/13506129.2014.964858","volume":"21","author":"JD Sipe","year":"2014","unstructured":"Sipe, J. D. et al. Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid 21, 221\u2013224 (2014).","journal-title":"Amyloid"},{"key":"22820_CR4","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1073\/pnas.93.8.3492","volume":"93","author":"CB Verchere","year":"1996","unstructured":"Verchere, C. B. et al. Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. P. Natl. Acad. Sci. USA 93, 3492\u20133496 (1996).","journal-title":"P. Natl. Acad. Sci. USA"},{"key":"22820_CR5","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1006\/jsbi.2000.4268","volume":"130","author":"C Goldsbury","year":"2000","unstructured":"Goldsbury, C. et al. Amyloid fibril formation from full-length and fragments of amylin. J. Struct. Biol. 130, 352\u2013362 (2000).","journal-title":"J. Struct. Biol."},{"key":"22820_CR6","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1111\/j.1742-4658.2006.05367.x","volume":"273","author":"B Konarkowska","year":"2006","unstructured":"Konarkowska, B., Aitken, J. F., Kistler, J., Zhang, S. & Cooper, G. J. The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells. FEBS J. 273, 3614\u20133624 (2006).","journal-title":"FEBS J."},{"key":"22820_CR7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJM200008103430607","volume":"343","author":"JW H\u00f6ppener","year":"2000","unstructured":"H\u00f6ppener, J. W., Ahr\u00e9n, B. & Lips, C. J. Islet amyloid and type 2 diabetes mellitus. New Engl. J. Med. 343, 411\u2013419 (2000).","journal-title":"New Engl. J. Med."},{"key":"22820_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/340272b0","volume":"340","author":"GJ Cooper","year":"1989","unstructured":"Cooper, G. J., Willis, A. C. & Leighton, B. Amylin hormone. Nature 340, 272 (1989).","journal-title":"Nature"},{"key":"22820_CR9","first-page":"527","volume":"5","author":"EL Opie","year":"1901","unstructured":"Opie, E. L. The relation of diabetes mellitus to lesions of the pancreas. Hyaline degeneration of the islands of langerhans. J. Exp. Med. 5, 527\u2013540 (1901).","journal-title":"Hyaline degeneration of the islands of langerhans. J. Exp. Med."},{"key":"22820_CR10","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.2337\/diab.42.10.1514","volume":"42","author":"A Novials","year":"1993","unstructured":"Novials, A., Sarri, Y., Casamitjana, R., Rivera, F. & Gomis, R. Regulation of islet amyloid polypeptide in human pancreatic islets. Diabetes 42, 1514\u20131519 (1993).","journal-title":"Diabetes"},{"key":"22820_CR11","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0022-2836(02)00164-X","volume":"318","author":"LA Scrocchi","year":"2002","unstructured":"Scrocchi, L. A. et al. Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis. J. Mol. Biol. 318, 697\u2013706 (2002).","journal-title":"J. Mol. Biol."},{"key":"22820_CR12","doi-asserted-by":"publisher","first-page":"5689","DOI":"10.1016\/j.bmcl.2012.06.089","volume":"22","author":"TY Lee","year":"2012","unstructured":"Lee, T. Y. et al. A Co(III) complex cleaving soluble oligomers of h-IAPP in the presence of polymeric aggregates of h-IAPP. Bioorg. Med. Chem. Lett. 22, 5689\u20135693 (2012).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"22820_CR13","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1016\/j.bmc.2010.02.045","volume":"18","author":"K Jeong","year":"2010","unstructured":"Jeong, K., Chung, W. Y., Kye, Y. S. & Kim, D. Cu(II) cyclen cleavage agent for human islet amyloid peptide. Bioorg. Med. Chem. 18, 2598\u20132601 (2010).","journal-title":"Bioorg. Med. Chem."},{"key":"22820_CR14","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1002\/anie.200705372","volume":"47","author":"R Mishra","year":"2008","unstructured":"Mishra, R. et al. Small-molecule inhibitors of islet amyloid polypeptide fibril formation. Angew. Chem. Int. Ed. 47, 4679\u20134682 (2008).","journal-title":"Angew. Chem. Int. Ed."},{"key":"22820_CR15","doi-asserted-by":"publisher","first-page":"e65579","DOI":"10.1371\/journal.pone.0065579","volume":"8","author":"J Zheng","year":"2013","unstructured":"Zheng, J. et al. Exploring the influence of carbon nanoparticles on the formation of \u03b2-sheet-rich oligomers of IAPP22\u201328 peptide by molecular dynamics simulation. PLoS ONE 8, e65579 (2013).","journal-title":"PLoS ONE"},{"key":"22820_CR16","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/smll.201502317","volume":"12","author":"EN Gurzov","year":"2016","unstructured":"Gurzov, E. N. et al. Inhibition of hIAPP amyloid aggregation and pancreatic \u03b2-cell toxicity by OH-terminated PAMAM dendrimer. Small 12, 1615\u20131626 (2016).","journal-title":"Small"},{"key":"22820_CR17","doi-asserted-by":"crossref","unstructured":"Klementieva, O. et al. Effect of poly(propylene imine) glycodendrimers on \u03b2-amyloid aggregation in vitro and in APP\/PS1 transgenic mice, as a model of brain amyloid deposition and Alzheimer\u2019s disease. Biomacromolecules 14, 3570-3580 (2013).","DOI":"10.1021\/bm400948z"},{"key":"22820_CR18","doi-asserted-by":"publisher","first-page":"e69652","DOI":"10.1371\/journal.pone.0069652","volume":"8","author":"J Seeliger","year":"2013","unstructured":"Seeliger, J., Werkm\u00fcller, A. & Winter, R. Macromolecular crowding as a suppressor of human IAPP fibril formation and cytotoxicity. PLoS ONE 8, e69652 (2013).","journal-title":"PLoS ONE"},{"key":"22820_CR19","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/jnci\/djm027","volume":"99","author":"N Tang","year":"2007","unstructured":"Tang, N. et al. Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin. J. Natl. Cancer Inst. 99, 1004\u20131015 (2007).","journal-title":"J. Natl. Cancer Inst."},{"key":"22820_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.biomaterials.2015.11.007","volume":"77","author":"X Fang","year":"2016","unstructured":"Fang, X. et al. Nano-cage-mediated refolding of insulin by PEG-PE micelle. Biomaterials 77, 139\u2013148 (2016).","journal-title":"Biomaterials"},{"key":"22820_CR21","doi-asserted-by":"publisher","first-page":"20120309","DOI":"10.1098\/rsta.2012.0309","volume":"371","author":"J Wang","year":"2013","unstructured":"Wang, J. et al. Cationic amphiphilic drugs self-assemble to the core-shell interface of PEGylated phospholipid micelles and stabilize micellar structure. Philos. T. Roy. Soc. A. 371, 20120309 (2013).","journal-title":"Philos. T. Roy. Soc. A."},{"key":"22820_CR22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jconrel.2012.02.021","volume":"160","author":"J Wang","year":"2012","unstructured":"Wang, J., Wang, Y. & Liang, W. Delivery of drugs to cell membranes by encapsulation in PEG-PE micelles. J. Control Release 160, 637\u2013651 (2012).","journal-title":"J. Control Release"},{"key":"22820_CR23","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.1021\/nn300571c","volume":"6","author":"J Wang","year":"2012","unstructured":"Wang, J., Fang, X. & Liang, W. Pegylated phospholipid micelles induce endoplasmic reticulum-dependent apoptosis of cancer cells but not normal cells. Acs Nano 6, 5018\u20135130 (2012).","journal-title":"Acs Nano"},{"key":"22820_CR24","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S0022-2836(65)80111-5","volume":"13","author":"L Stryer","year":"1965","unstructured":"Stryer, L. The interaction of napthalene dye with apomyoglobin and apohemoglobin. A fluorescent probe of non-polar binding sites. J. Mol. Biol. 13, 482\u2013495 (1965).","journal-title":"J. Mol. Biol."},{"key":"22820_CR25","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1021\/js960297s","volume":"86","author":"J Brange","year":"1997","unstructured":"Brange, J., Andersen, L., Laursen, E. D., Meyn, G. & Rasmussen, E. Toward understanding insulin fibrillation. J. Pharm. Sci. 86, 517\u2013525 (1997).","journal-title":"J. Pharm. Sci."},{"key":"22820_CR26","doi-asserted-by":"publisher","first-page":"8596","DOI":"10.1016\/j.biomaterials.2014.06.056","volume":"35","author":"X Li","year":"2014","unstructured":"Li, X., Ma, L., Zheng, W. & Chen, T. Inhibition of islet amyloid polypeptide fibril formation by selenium-containing phycocyanin and prevention of beta cell apoptosis. Biomaterials 35, 8596\u20138604 (2014).","journal-title":"Biomaterials"},{"key":"22820_CR27","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.bbrc.2016.11.083","volume":"482","author":"JF Aitken","year":"2017","unstructured":"Aitken, J. F. et al. Rutin suppresses human-amylin\/hIAPP misfolding and oligomer formation in-vitro, and ameliorates diabetes and its impacts in human-amylin\/hIAPP transgenic mice. Biochem. Bioph. Res. Co. 482, 625\u2013631 (2017).","journal-title":"Biochem. Bioph. Res. Co."},{"key":"22820_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jsb.2009.05.009","volume":"167","author":"X Mao","year":"2009","unstructured":"Mao, X. et al. Structural characteristics of the beta-sheet-like human and rat islet amyloid polypeptides as determined by scanning tunneling microscopy. J. Struct. Biol. 167, 209\u2013215 (2009).","journal-title":"J. Struct. Biol."},{"key":"22820_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejphar.2013.03.017","volume":"707","author":"S Bahramikia","year":"2013","unstructured":"Bahramikia, S. & Yazdanparast, R. Inhibition of human islet amyloid polypeptide or amylin aggregation by two manganese-salen derivatives. Eur. J. Pharmacol. 707, 17\u201325 (2013).","journal-title":"Eur. J. Pharmacol."},{"key":"22820_CR30","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1021\/ja310064v","volume":"135","author":"M Richman","year":"2013","unstructured":"Richman, M. et al. In vitro and mechanistic studies of an antiamyloidogenic self-assembled cyclic D,L-alpha-peptide architecture. J. Am. Chem. Soc. 135, 3474\u20133484 (2013).","journal-title":"J. Am. Chem. Soc."},{"key":"22820_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1750-1326-2-18","volume":"2","author":"R Kayed","year":"2007","unstructured":"Kayed, R. et al. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol. Neurodegener. 2, 18\u201328 (2007).","journal-title":"Mol. Neurodegener."},{"key":"22820_CR32","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/416507a","volume":"416","author":"M Bucciantini","year":"2002","unstructured":"Bucciantini, M. et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507\u2013511 (2002).","journal-title":"Nature"},{"key":"22820_CR33","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2337\/diabetes.48.3.491","volume":"48","author":"J Janson","year":"1999","unstructured":"Janson, J., Ashley, R. H., Harrison, D., Mcintyre, S. & Butler, P. C. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 48, 491\u2013498 (1999).","journal-title":"Diabetes"},{"key":"22820_CR34","doi-asserted-by":"publisher","first-page":"46363","DOI":"10.1074\/jbc.C400260200","volume":"279","author":"R Kayed","year":"2004","unstructured":"Kayed, R. et al. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem. 279, 46363\u201346366 (2004).","journal-title":"J. Biol. Chem."},{"key":"22820_CR35","doi-asserted-by":"publisher","first-page":"8908","DOI":"10.1021\/bi9006397","volume":"48","author":"W Qi","year":"2009","unstructured":"Qi, W., Zhang, A., Good, T. A. & Fernandez, E. J. Two disaccharides and trimethylamine N-oxide affect Abeta aggregation differently, but all attenuate oligomer-induced membrane permeability. Biochemistry 48, 8908\u20138919 (2009).","journal-title":"Biochemistry"},{"key":"22820_CR36","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s00125-008-1255-x","volume":"52","author":"S Zraika","year":"2009","unstructured":"Zraika, S. et al. Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis. Diabetologia 52, 626\u2013635 (2009).","journal-title":"Diabetologia"},{"key":"22820_CR37","doi-asserted-by":"publisher","first-page":"4949","DOI":"10.1111\/j.1742-4658.2005.04903.x","volume":"272","author":"B Konarkowska","year":"2005","unstructured":"Konarkowska, B., Aitken, J. F., Kistler, J., Zhang, S. & Cooper, G. J. Thiol reducing compounds prevent human amylin-evoked cytotoxicity. FEBS J. 272, 4949\u20134959 (2005).","journal-title":"FEBS J."},{"key":"22820_CR38","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1152\/physrev.00042.2009","volume":"91","author":"P Westermark","year":"2011","unstructured":"Westermark, P., Andersson, A. & Westermark, G. T. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol. Rev. 91, 795\u2013826 (2011).","journal-title":"Physiol. Rev."},{"key":"22820_CR39","first-page":"1759","volume-title":"ACS Chem. Neurosci.","author":"R Hu","year":"2015","unstructured":"Hu, R., Zhang, M., Chen, H., Jiang, B. & Zheng, J. Cross-seeding interaction between beta-amyloid and human islet amyloid polypeptide. ACS Chem. Neurosci. 6, 1759\u20131768 (2015)."},{"key":"22820_CR40","doi-asserted-by":"publisher","first-page":"4443","DOI":"10.1016\/j.biomaterials.2012.03.024","volume":"33","author":"HM Chan","year":"2012","unstructured":"Chan, H. M. et al. Effect of surface-functionalized nanoparticles on the elongation phase of beta-amyloid (1-40) fibrillogenesis. Biomaterials 33, 4443\u20134450 (2012).","journal-title":"Biomaterials"},{"key":"22820_CR41","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1039\/C5CP05924K","volume":"18","author":"P Nedumpully-Govindan","year":"2016","unstructured":"Nedumpully-Govindan, P. et al. Graphene oxide inhibits hIAPP amyloid fibrillation and toxicity in insulin-producing NIT-1 cells. Phys. Chem. Chem. Phys. 18, 94\u2013100 (2016).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"22820_CR42","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","volume":"160","author":"Y Barenholz","year":"2012","unstructured":"Barenholz, Y. Doxil\u00ae\u2013the first FDA-approved nano-drug: lessons learned. J. Control Release 160, 117\u2013134 (2012).","journal-title":"J. Control Release"},{"key":"22820_CR43","doi-asserted-by":"publisher","first-page":"13505","DOI":"10.1021\/bi701427q","volume":"46","author":"S Luca","year":"2007","unstructured":"Luca, S., Yau, W., Leapman, R. & Tycko, R. Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid state NMR. Biochemistry 46, 13505\u201313522 (2007).","journal-title":"Biochemistry"},{"key":"22820_CR44","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0925-4439(01)00078-3","volume":"1537","author":"E Jaikaran","year":"2001","unstructured":"Jaikaran, E. & Clark, A. Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology. Biochim. Biophys. Acta 1537, 179\u2013203 (2001).","journal-title":"Biochim. Biophys. Acta"},{"key":"22820_CR45","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrd3373","volume":"10","author":"O Kepp","year":"2011","unstructured":"Kepp, O., Galluzzi, L., Lipinski, M., Yuan, J. & Kroemer, G. Cell death assays for drug discovery. Nat. Rev. Drug Discov. 10, 221\u2013237 (2011).","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22820-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22820-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22820-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T03:23:06Z","timestamp":1671592986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22820-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,13]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["22820"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-22820-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,13]]},"assertion":[{"value":"10 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"4463"}}